How do you treat the pain of medical patients who have a history of substance use disorders? Katie Fitzgerald Jones's ...

Dissolve under tongue; do not chew or swallow. The use of buprenorphine HCl sublingual tablets for unsupervised administration should be limited to those patients who cannot tolerate buprenorphine ...

Objective: To evaluate pharmaceutical and pharmacotherapeutic differences in oral opioid modified-release products used in the management of chronic pain ... of MS Contin tablets); however ...

and MS Contin ® tablets (administered twice daily), in the treatment of chronic cancer pain. Patients and Methods: A randomised, open-label, multicentre, crossover study was conducted in 178 ...